Cargando…

Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence

BACKGROUND: The aim of this study was to explore the risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and investigate the effect of octreotide combined with nonsteroidal anti-inflammatory drugs on preventing its occurrence. MATERIAL/METHODS: A total of 139 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jin, Shen, Yiyu, Zhong, Zhengxiang, Wu, Shaohan, Zheng, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299780/
https://www.ncbi.nlm.nih.gov/pubmed/30531679
http://dx.doi.org/10.12659/MSM.911914
_version_ 1783381561245171712
author Wang, Jin
Shen, Yiyu
Zhong, Zhengxiang
Wu, Shaohan
Zheng, Liping
author_facet Wang, Jin
Shen, Yiyu
Zhong, Zhengxiang
Wu, Shaohan
Zheng, Liping
author_sort Wang, Jin
collection PubMed
description BACKGROUND: The aim of this study was to explore the risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and investigate the effect of octreotide combined with nonsteroidal anti-inflammatory drugs on preventing its occurrence. MATERIAL/METHODS: A total of 139 patients undergoing ERCP in our hospital from May 2016 to April 2017 were retrospectively analyzed, and divided into an observation group (n=67) (octreotide + indomethacin) and a control group (n=72) (no preventive drugs). The preoperative and postoperative inflammatory cytokines such as tumor necrosis factor-α (TNF)-α, interleukin-6 (IL-6) and IL-8, and serum amylase levels were measured, and the incidence of pancreatitis and hyper amylasemia were monitored. RESULTS: Serum amylase level was increased significantly 3 hours after operation in both groups with significantly higher level in the control group compared to the observation group. After 24 hours, serum amylase in the observation group was decreased to preoperative level, whereas it was still higher than preoperative in the control group (P<0.05). Regarding the levels of TNF-α, IL-6, IL-8, and visual analogue scale, they were significantly increased in both groups after operation with significantly higher levels in the control group compared to the observation group (P<0.05). Furthermore, logistic regression analysis showed that difficult intubation, pancreatic duct angiography, surgery for a long time, and the history of previous pancreatitis were risk factors for post-ERCP pancreatitis (P<0.05). CONCLUSIONS: Difficult intubation, pancreatic duct angiography, surgery for a long time, and the history of previous pancreatitis were risk factors for post-ERCP pancreatitis. Octreotide combined with non-steroidal anti-inflammatory drugs can reduce the pain of patients with abdominal pain as well as the incidence of postoperative pancreatitis, indicating that they might be effective preventative approaches for pancreatitis.
format Online
Article
Text
id pubmed-6299780
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-62997802019-01-14 Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence Wang, Jin Shen, Yiyu Zhong, Zhengxiang Wu, Shaohan Zheng, Liping Med Sci Monit Clinical Research BACKGROUND: The aim of this study was to explore the risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and investigate the effect of octreotide combined with nonsteroidal anti-inflammatory drugs on preventing its occurrence. MATERIAL/METHODS: A total of 139 patients undergoing ERCP in our hospital from May 2016 to April 2017 were retrospectively analyzed, and divided into an observation group (n=67) (octreotide + indomethacin) and a control group (n=72) (no preventive drugs). The preoperative and postoperative inflammatory cytokines such as tumor necrosis factor-α (TNF)-α, interleukin-6 (IL-6) and IL-8, and serum amylase levels were measured, and the incidence of pancreatitis and hyper amylasemia were monitored. RESULTS: Serum amylase level was increased significantly 3 hours after operation in both groups with significantly higher level in the control group compared to the observation group. After 24 hours, serum amylase in the observation group was decreased to preoperative level, whereas it was still higher than preoperative in the control group (P<0.05). Regarding the levels of TNF-α, IL-6, IL-8, and visual analogue scale, they were significantly increased in both groups after operation with significantly higher levels in the control group compared to the observation group (P<0.05). Furthermore, logistic regression analysis showed that difficult intubation, pancreatic duct angiography, surgery for a long time, and the history of previous pancreatitis were risk factors for post-ERCP pancreatitis (P<0.05). CONCLUSIONS: Difficult intubation, pancreatic duct angiography, surgery for a long time, and the history of previous pancreatitis were risk factors for post-ERCP pancreatitis. Octreotide combined with non-steroidal anti-inflammatory drugs can reduce the pain of patients with abdominal pain as well as the incidence of postoperative pancreatitis, indicating that they might be effective preventative approaches for pancreatitis. International Scientific Literature, Inc. 2018-12-11 /pmc/articles/PMC6299780/ /pubmed/30531679 http://dx.doi.org/10.12659/MSM.911914 Text en © Med Sci Monit, 2018 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Wang, Jin
Shen, Yiyu
Zhong, Zhengxiang
Wu, Shaohan
Zheng, Liping
Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
title Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
title_full Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
title_fullStr Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
title_full_unstemmed Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
title_short Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
title_sort risk factors for post-endoscopic retrograde cholangiopancreatography (ercp) pancreatitis and the effect of octreotide combined with nonsteroidal anti-inflammatory drugs on preventing its occurrence
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299780/
https://www.ncbi.nlm.nih.gov/pubmed/30531679
http://dx.doi.org/10.12659/MSM.911914
work_keys_str_mv AT wangjin riskfactorsforpostendoscopicretrogradecholangiopancreatographyercppancreatitisandtheeffectofoctreotidecombinedwithnonsteroidalantiinflammatorydrugsonpreventingitsoccurrence
AT shenyiyu riskfactorsforpostendoscopicretrogradecholangiopancreatographyercppancreatitisandtheeffectofoctreotidecombinedwithnonsteroidalantiinflammatorydrugsonpreventingitsoccurrence
AT zhongzhengxiang riskfactorsforpostendoscopicretrogradecholangiopancreatographyercppancreatitisandtheeffectofoctreotidecombinedwithnonsteroidalantiinflammatorydrugsonpreventingitsoccurrence
AT wushaohan riskfactorsforpostendoscopicretrogradecholangiopancreatographyercppancreatitisandtheeffectofoctreotidecombinedwithnonsteroidalantiinflammatorydrugsonpreventingitsoccurrence
AT zhengliping riskfactorsforpostendoscopicretrogradecholangiopancreatographyercppancreatitisandtheeffectofoctreotidecombinedwithnonsteroidalantiinflammatorydrugsonpreventingitsoccurrence